Jarl Securities is responsible for the independent coverage of the company, follow the link to the latest analysis in… Read more
CEO Carlos de Sousa will present the Company as well as provide background on the proposed Rights Issue… Read more
En webbpresentation som beskriver Företrädesemissionen kommer att finnas tillgänglig på Immunicums webbplats från kl. 12.00 idag, tisdagen den… Read more
An online presentation covering the Rights Issue will be available on Immunicum’s website starting at 12:00 noon CET… Read more
When: 8-15 July 2017 Venue: Paris, France is the end destination. More info about the Nordic charity cycling… Read more
Our recent publication data were featured in labiotech in the article “Swedish Biotech publishes Long-Term Data on a… Read more
CEO Carlos de Sousa recently participated in an immuno-oncology focused panel at the labiotech refresh conference in Berlin,… Read more
Immuncum will attend Småbolagsdagen on June 12, 2017 at the Sheraton Hotel Stockholm. CEO Carlos de Sousa will… Read more
Immunicum is proud to again support Barncancerfonden, The Swedish Childhood Cancer Foundation, and for the first time, Team… Read more
Immunicum was featured in Blue Steens in the article “Immunicum – Scalable Personalized Cancer Immunotherapy” on January 2,… Read more
